secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-11-24T23:59:59+00:00
Accession:  0001104659-23-120977
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics receives Nasdaq delisting notice for continued non-compliance with equity rule
--------------------------------------------------------------------------------

- Failed to meet Nasdaq's $2.5M stockholders' equity requirement by Nov 15, 2023 extension deadline.
- Staff notified of delisting determination on Nov 20, 2023; company to request hearing to stay delisting.
- No immediate effect on trading; stock continues on Nasdaq under ATXI pending hearing outcome.
- Company cannot assure that panel will grant continued listing or that compliance can be shown within any extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923120977/0001104659-23-120977-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923120977/tm2331507d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-120977

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer